Cramer Remix: The new supercharged version of Abbvie is worth a buy

7:37 PM ET Fri, 20 Sept 2019

Jim Cramer breaks down why the Abbvie-Allergan tie-up is a better bet at this level than the Bristol Myers-Celgene combination.